CNR Institutional Research Information System

CATALUCCI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.670
NA - Nord America 1.141
EU - Europa 451
SA - Sud America 288
Continente sconosciuto - Info sul continente non disponibili 203
AF - Africa 34
Totale 3.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.077
SG - Singapore 661
CN - Cina 442
BR - Brasile 218
VN - Vietnam 171
IT - Italia 148
HK - Hong Kong 131
FR - Francia 87
KR - Corea 77
NL - Olanda 77
BD - Bangladesh 48
JP - Giappone 37
GB - Regno Unito 29
FI - Finlandia 28
IN - India 27
AR - Argentina 24
DE - Germania 22
ID - Indonesia 20
CA - Canada 18
MX - Messico 14
VE - Venezuela 11
ZA - Sudafrica 11
EC - Ecuador 10
CO - Colombia 8
CR - Costa Rica 8
IL - Israele 8
MA - Marocco 8
PL - Polonia 8
AT - Austria 7
PK - Pakistan 7
TR - Turchia 7
CL - Cile 6
JM - Giamaica 6
UA - Ucraina 6
IE - Irlanda 5
PE - Perù 5
PH - Filippine 4
SE - Svezia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
BE - Belgio 3
CH - Svizzera 3
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
JO - Giordania 3
NP - Nepal 3
RU - Federazione Russa 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GP - Guadalupe 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
LV - Lettonia 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
NI - Nicaragua 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
UY - Uruguay 1
Totale 3.584
Salva come PNG Salva come JPEG
Città #
Singapore 393
Santa Clara 277
Hefei 185
Hong Kong 128
Ashburn 117
San Jose 115
Beijing 85
Seoul 77
Lauterbourg 67
Ho Chi Minh City 62
Los Angeles 50
Hanoi 37
New York 26
Tokyo 25
Dallas 24
Milan 23
Lappeenranta 19
Orem 15
Pisa 14
Buffalo 13
São Paulo 13
Council Bluffs 12
Bologna 11
Frankfurt am Main 10
Minamishinagawa 10
Atlanta 9
Cagliari 9
Da Nang 9
Rio de Janeiro 9
Chicago 8
Denver 8
Helsinki 8
Warsaw 8
Querétaro 7
Rome 7
Brasília 6
Brescia 6
Brooklyn 6
Chennai 6
Johannesburg 6
Montreal 6
Phoenix 6
San José 6
Vienna 6
Amsterdam 5
Baltimore 5
Bengaluru 5
Charlotte 5
Curitiba 5
Guayaquil 5
Houston 5
Jakarta 5
Naples 5
Poplar 5
Porto Alegre 5
Queens 5
The Bronx 5
Belo Horizonte 4
Caracas 4
Dublin 4
Düsseldorf 4
Hyderabad 4
Kingston 4
Lima 4
Marseille 4
Miami 4
Quito 4
Salvador 4
San Antonio 4
San Francisco 4
Stockholm 4
Amman 3
Assemini 3
Boardman 3
Brussels 3
Budapest 3
Bắc Ninh 3
Cali 3
Campinas 3
Cape Town 3
Casablanca 3
City of London 3
Faenza 3
Fresno 3
Guangzhou 3
Guiyang 3
Haiphong 3
Kyiv 3
London 3
Manila 3
Mumbai 3
Pasadena 3
Philadelphia 3
Piscataway 3
Quảng Ngãi 3
Quận Một 3
Shanghai 3
Tashkent 3
Thái Nguyên 3
Wuppertal 3
Totale 2.152
Salva come PNG Salva come JPEG
Nome #
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 126
Calcium Phosphate Nanoparticles as Carriers of Therapeutic Peptides 104
Calcium Phosphate Nanoparticle Precipitation by a Continuous Flow Process: A Design of an Experiment Approach 102
T cell costimulation blockade blunts pressure overload-induced heart failure 95
Synthetic recovery of impulse propagation in myocardial infarction via silicon carbide semiconductive nanowires 86
Bio-Inspired Negatively-Charged Calcium Phosphate Nanocarriers for Cardiac Delivery of MicroRNAs 85
MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. 84
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 84
Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression 83
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 81
Biocompatible antimicrobial colistin loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infections 77
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 72
Inhalation of peptide-loaded nanoparticles improves heart failure 72
Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure 72
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 70
Peptidomimetic Targeting of Cav?2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function 69
MicroRNA-133 Controls Vascular Smooth Muscle Cell Phenotypic Switch In Vitro and Vascular Remodeling In Vivo 67
Diagnostic and Therapeutic Aptamers A Promising Pathway to Improved Cardiovascular Disease Management 66
MODULATION OF LTCC PATHWAYS BY A MELUSIN MIMETIC INCREASES VENTRICULAR CONTRACTILITY DURING LPS-INDUCED CARDIOMYOPATHY 66
Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells 64
The noncoding-RNA landscape in cardiovascular health and disease 63
Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review 62
MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium. 62
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 61
Myopalladin knockout mice develop cardiac dilation and show a maladaptive response to mechanical pressure overload 60
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug ... 59
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis 59
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 58
Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases 57
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases 56
MicroRNA-133 modulates the b1-adrenergic receptor transduction cascade 54
Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System 54
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 50
Disease modeling of a mutation in a-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy 50
The Circulating Level of FABP3 Is an Indirect Biomarker of MicroRNA-1 48
An anti-PDGFR aptamer for selective delivery of small therapeutic peptide to cardiac cells 46
The role of mitochondrial dynamics in cardiovascular diseases 44
MicroRNA-133 controls cardiac myocyte hypertrophy 44
Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction 44
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. 43
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice (vol 120, pg 2805, 2010) 42
Cardiovascular nanomedicine: The route ahead 42
Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 41
A comparative MudPIT analysis identifies different expression profiles in heart compartments. 40
Computational simulation of electromagnetic fields on human targets for magnetic targeting applications 40
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. 39
Biocompatible and inhalable antimicrobial-loaded nanoparticles for the counteraction of biofilm formation and antibiotic resistance: towards a potential new therapy for CF related infections 39
Physiological myocardial hypertrophy: how and why? 38
An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. 37
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 37
Role of electromagnetic stimulation on cardiac cells activity and on magnetic nanoparticles for drug delivery to the heart 36
Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. 35
FABP3 as a Biomarker of Heart Pathology 35
The recent blooming of therapeutic aptamers 35
Genome-wide microRNA target gene identification and annotation using multiple prediction algorithms 34
NF-kB mediated miR-26a regulation in cardiac fibrosis. 34
High Intensity Interval Training Ameliorates Mitochondrial Dysfunction in the Left Ventricle of Mice with Type 2 Diabetes 32
Akt regulates L-type Ca2+ channel activity by modulating Cava1 protein stability 29
Nano-Apatites with Designed Chemistry and Crystallinity for Bone Regeneration and Nanomedical Applications 28
Enhancement of mitochondrial calcium uptake is cardioprotective against maladaptive hypertrophy by retrograde signaling uptuning Akt 27
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. 27
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 27
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. 27
MicroRNAs: novel regulators in cardiac development and disease. 26
MicroRNAs and the control of heart pathophysiology 25
A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs 24
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice 24
Exercise training reverses myocardial dysfunction induced by CaMKII?C overexpression by restoring Ca2+ homeostasis. 24
MiR-133a Regulates Collagen 1A1: Potential Role of miR-133a in Myocardial Fibrosis in Angiotensin II-Dependent Hypertension 23
Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy 23
HEXIM1: a new player in myocardial hypertrophy? 22
AKT INCREASES SARCOPLASMIC RETICULUM CA2+ CYCLING BY DIRECT PHOSPHORYLATION OF PHOSPHOLAMBAN (PLN) AT THR17 21
MiR-153/Kv7.4: a novel molecular axis in the regulation of hypertension 21
APJ acts as a dual receptor in cardiac hypertrophy. 19
Cardiovascular inhalation for targeted drug delivery in cardiac disease 18
Reduced aerobic capacity causes leaky ryanodine receptors that trigger arrhythmia in a rat strain artificially selected and bred for low aerobic running capacity 17
Totale 3.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.561
article - articoli 11.634
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 355
Totale 24.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 0 10 2
2024/20251.296 8 6 96 36 332 81 89 62 46 97 246 197
2025/20262.129 131 219 196 336 343 113 325 104 117 109 70 66
2026/2027350 131 69 150 0 0 0 0 0 0 0 0 0
Totale 3.787